Antifungal therapy – Page 4

Detection and diagnostic process of liver abscess secondary to chemotherapy by mucor indicus in a patient with acute leukemic disease: case report

mycolabadmin

A 60-year-old man with acute leukemia developed a serious fungal infection in his liver caused by Mucor indicus after receiving chemotherapy that weakened his immune system. Doctors identified the infection through tissue samples and genetic testing, then treated him successfully with antifungal medications amphotericin B and posaconazole. This case highlights the importance of early detection and proper diagnosis of rare fungal infections in cancer patients undergoing chemotherapy.

Simultaneous infection with Fusarium proliferatum and Prototheca wickerhamii localized at different body sites

mycolabadmin

An 81-year-old woman taking long-term steroid medication developed two different fungal skin infections on her hands simultaneously – one on the right hand from a moldy wooden frame and one on the left hand possibly from sewage exposure. Doctors identified both fungi through microscopy and genetic testing. She was successfully treated with an antifungal medication called voriconazole for four weeks and recovered completely.

Fungal Infections – a Stealthy Enemy in Patients with Chronic Granulomatous Disease: a 28-years’ Experience from North India

mycolabadmin

Patients with chronic granulomatous disease (CGD), a rare immune system disorder, are highly susceptible to serious fungal infections. This study of 99 patients over 28 years found that 40% developed fungal infections, mostly caused by Aspergillus fungi affecting the lungs. These infections were life-threatening, with over half the infected patients dying despite aggressive treatment with antifungal medications. Doctors need to screen for fungal infections early, even in patients without obvious symptoms, and treat infants and males more aggressively.

Brazilian task force for the management of mucormycosis

mycolabadmin

Mucormycosis is a serious fungal infection that has become more common in Brazil, especially during COVID-19. This medical emergency requires rapid diagnosis through imaging and tissue sampling, combined with aggressive treatment including antifungal medications and surgery to remove infected tissue. The Brazilian government has made these powerful antifungal drugs more available to improve patient survival and reduce the severe complications of this dangerous infection.

Superficial abdominal surgical site infection caused by Aspergillus welwitschiae: a case report

mycolabadmin

An elderly woman developed a rare fungal infection in her abdominal surgical wound after surgery for a perforated colon. The infection was caused by Aspergillus welwitschiae, a mold that was initially thought to be a more common species. Doctors treated the infection by surgically removing the infected tissue and giving the patient an antifungal medication called voriconazole. This is the first reported case of this particular mold causing this type of surgical infection.

Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth

mycolabadmin

Researchers studied how Trikafta, a new cystic fibrosis medication, affects Aspergillus fungus growth. While Trikafta doesn’t directly kill the fungus, it makes antifungal drugs more effective and improves patients’ lung function to help clear infections naturally. However, high concentrations of the drug may reduce the immune system’s ability to fight the fungus, suggesting careful monitoring of patients is needed.

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

mycolabadmin

A 65-year-old woman who received a lung transplant developed a serious brain infection caused by a rare fungus called Rasamsonia argillacea. Doctors initially struggled to identify this unusual fungus and treated her with multiple antifungal medications, but the infection proved difficult to control because the fungus was resistant to common antifungal drugs. Investigations revealed that the patient had an undiagnosed immune system disorder called chronic granulomatous disease, which made her vulnerable to this rare infection. Despite aggressive treatment including surgery and powerful antifungal medications, the patient’s condition worsened and she eventually passed away.

A Unique Case of Fungal Endometritis Caused by Aspergillus quadrilineatus in an Immunocompetent Woman and Literature Review

mycolabadmin

A 64-year-old woman experienced persistent vaginal bleeding for three months, which was found to be caused by a rare fungal infection (Aspergillus quadrilineatus) in her uterus. Through tissue examination and molecular testing, doctors identified the fungus and found it was sensitive to common antifungal medications. The patient was successfully treated with antifungal medication combined with surgical cleaning of the uterus, making a complete recovery. This case highlights that fungal infections should be considered when patients have abnormal vaginal bleeding, even if they appear otherwise healthy.

Influenza-related invasive pulmonary aspergillosis in an infectious disease ward at a pulmonary referral center in Iran

mycolabadmin

This study examined patients hospitalized with influenza who developed a serious fungal infection caused by Aspergillus fungus. Among 109 influenza patients, about 9% developed this fungal complication which significantly increased their risk of death and required longer hospital stays. Patients with existing lung diseases were at higher risk, and those with the fungal infection also had more bacterial superinfections. The findings highlight the importance of recognizing and treating this serious fungal complication in hospitalized influenza patients.

Severe Saprochaete capitata fungemia presenting as micafungin breakthrough hepatosplenic lesions in an immunocompromised patient: case report

mycolabadmin

A 70-year-old woman with blood cancer developed a serious fungal blood infection caused by Saprochaete capitata, a rare soil fungus, despite taking preventive antifungal medication. The infection spread to her liver and spleen, creating multiple lesions and a dangerous aneurysm. Doctors successfully treated her with a combination of three antifungal drugs, particularly voriconazole, which proved more effective than the initial preventive medication. This case highlights how rare fungi can cause severe infections in cancer patients and the importance of recognizing when standard preventive treatments are not working.

Research Topic: Antifungal therapy